Answers are grounded in this paper and cite their sources.
Malnutrition, systemic inflammation, and treatment-related toxicity may compromise radiotherapy tolerance in patients with head and neck squamous cell carcinoma (HNSCC). We evaluated a structured nutrition-centred multidisciplinary supportive-care program during precision radiotherapy. This prospective cohort included 258 patients with HNSCC receiving intensity-modulated or volumetric-modulated arc radiotherapy. Patients entered the comprehensive nutritional management (CNM) group ( n = 129) or usual care (UC) group ( n = 129) according to program availability. Outcomes included radiotherapy interruption, Grade ≥ 3 oral mucositis, treatment delay, longitudinal nutritional and inflammatory markers, quality of life, and exploratory survival outcomes. Linear mixed-effects, parsimonious logistic, and Cox regression models were used. Radiotherapy completion without major interruption was 95.3% in the CNM group and 89.1% in the UC group ( P = 0.063). Grade ≥ 3 oral mucositis was less frequent with CNM (14.0% vs. 26.4%; P = 0.013), as was Grade ≥ 2 dysphagia (17.1% vs. 28.7%; P = 0.026). Treatment delay was shorter with CNM [2 (IQR 1–3) vs. 5 (IQR 3–7) days; P = 0.018]. CNM was associated with more favorable longitudinal trajectories of PNI, SII, global health status, and swallowing symptoms (all interaction P ≤ 0.020). Adjusted analyses showed lower odds of severe mucositis (OR, 0.50; 95% CI, 0.27–0.92), while the association with major interruption was not statistically significant (OR, 0.43; 95% CI, 0.17–1.05). A structured nutrition-centred multidisciplinary supportive-care program was associated with lower treatment-related toxicity, shorter delays, and more favorable nutritional, inflammatory, and quality-of-life trajectories during radiotherapy.
No takes yet. Share an insight, caveat, or question.
Su et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: